NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-154-1993-0-US-01 IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY US ORD 08/063,315 5419900 Expired PDF
NCI E-216-1987-1-US-02 METHOD FOR DETECTING CARCINOMA US FWC 08/062,717 5604106 Abandoned PDF
NCI E-152-1991-1-US-01 Peptides Which Elicit A High Neutralizing Antibody Titer, Cytotoxic T Lymphocyte Response and T Helper Cell Response In A Broad Range of... US CIP 08/060,988 6294322 Expired PDF
NCI E-149-1993-0-US-01 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE US ORD 08/061,889 5654138 Expired PDF
NHLBI E-152-1993-0-PCT-02 Vector Particles Resistant to Inactivation by Human Serum PCT PCT PCT/US93/04706 Expired
NHLBI E-156-1992-0-PCT-02 No_Patent_Title PCT PCT PCT/US93/004707 Expired
NHLBI E-152-1993-0-JP-06 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM JP National Stage 05-501479 Expired
NHLBI E-156-1992-0-EP-04 IMPROVED EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND IMPROVED SELECTION OF CELLS TRANSDUCED WITH SUCH GENES EP National Stage 93913965.5 Expired
NHLBI E-152-1993-0-EP-05 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM EP National Stage 93913964.8 Abandoned
NHLBI E-152-1993-0-CA-04 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM CA National Stage 2137361 Abandoned
NCI E-146-1992-0-DK-16 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY DK EP 93911242.1 Expired
NCI E-146-1992-0-IE-18 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY IE EP 93911242.1 Expired
NCI E-146-1992-0-IT-13 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY IT EP 93911242.1 Expired
NCI E-146-1992-0-NL-21 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY NL EP 93911242.1 Expired
NCI E-146-1992-0-LU-19 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY LU EP 93911242.1 Expired
NCI E-146-1992-0-MC-20 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY MC EP 93911242.1 Expired
NCI E-146-1992-0-CH-07 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY CH EP 93911242.1 Expired
NCI E-146-1992-0-ES-10 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY ES EP 93911242.1 Expired
NCI E-146-1992-0-SE-03 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY SE EP 93911242.1 Expired
NCI E-146-1992-0-PT-22 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY PT EP 93911242.1 Expired
NCI E-146-1992-0-DE-08 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY DE EP 93911242.1 Expired
NCI E-146-1992-0-FR-11 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY FR EP 93911242.1 Expired
NCI E-146-1992-0-GR-17 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY GR EP 3034641 Expired
NCI E-146-1992-0-GB-12 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY GB EP 93911242.1 Expired
NCI E-146-1992-0-AT-04 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY AT EP 93911242.1 Expired
NCI E-146-1992-0-BE-15 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY BE EP 93911242.1 Expired
NIDDK E-597-1987-0-US-03 CARBOHYDRATE RECEPTOR FOR BACTERIA AND METHOD FOR USE THEREOF US CON 08/060,134 5386027 Expired PDF
NINDS E-123-1989-4-PCT-02 No_Patent_Title PCT PCT PCT/US93/004364 Expired
NCI E-146-1992-0-JP-14 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY JP National Stage 6-500936 Abandoned
NIAID E-240-1995-0-US-01 HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES US CIP 08/246,983 Abandoned
NIAID E-154-1994-0-US-01 HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES US ORD 08/060,978 Abandoned
NCI E-146-1992-0-CA-06 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY CA National Stage 2135312 Expired
NCI E-146-1992-0-EP-09 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY EP National Stage 93911242.1 Expired
NCI E-146-1992-0-AU-05 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY AU National Stage 42443/93 Expired
NCI E-146-1992-0-PCT-02 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY PCT PCT PCT/US1993/004454 Expired
NCI E-015-2007-1-US-01 Treatment Of Malignant Tumors With 8-chloroadenosine 3',5'-cyclic Monophasphate US CIP 08/438,537 5763419 Expired PDF
NICHD E-222-1992-0-US-01 INCREASED EXPRESSION OF ALPHA-1-ANTITRYPSIN IN EXPRESSION VECTORS THROUGH THE INCLUSION OF INTRON II US ORD 08/060,925 5439824 Expired PDF
NCI E-147-1993-0-US-01 For Method of Evaluating Chemotherapeutic Agents in Vivo US ORD 08/058,154 5698413 Abandoned PDF
NIMH E-289-1988-4-PCT-02 Evaluative means for detecting inflammatory reactivity PCT PCT PCT/US93/004070 Abandoned
NCI E-142-1993-0-US-01 KGF Receptor-Derived Antagonists of KGF Binding US ORD 08/059,030 5578566 Expired PDF
NCI E-040-1992-0-ES-12 BYSTANDER EFFECT TUMORICIDAL THERAPY ES EP 93910880.9 Abandoned
NCI E-040-1992-0-PT-21 BYSTANDER EFFECT TUMORICIDAL THERAPY PT EP 93910880.9 Abandoned
NCI E-040-1992-0-CH-08 BYSTANDER EFFECT TUMORICIDAL THERAPY CH EP 93910880.9 Abandoned
NCI E-040-1992-0-SE-22 BYSTANDER EFFECT TUMORICIDAL THERAPY SE EP 93910880.9 Abandoned
NCI E-040-1992-0-BE-11 BYSTANDER EFFECT TUMORICIDAL THERAPY BE EP 93910880.9 Abandoned
NCI E-040-1992-0-AT-07 BYSTANDER EFFECT TUMORICIDAL THERAPY AT EP 93910880.9 Abandoned
NCI E-040-1992-0-GR-15 BYSTANDER EFFECT TUMORICIDAL THERAPY GR EP 3025493 Abandoned
NCI E-040-1992-0-IT-17 BYSTANDER EFFECT TUMORICIDAL THERAPY IT EP 93910880.9 Abandoned
NCI E-040-1992-0-IE-16 BYSTANDER EFFECT TUMORICIDAL THERAPY IE EP 93910880.9 Abandoned
NCI E-040-1992-0-EP-05 BYSTANDER EFFECT TUMORICIDAL THERAPY EP National Stage 93910880.9 Expired